CIFoundry

How to evaluate clinical documentation AI

Documentation AI is the most widely bought category of clinical AI, and the one used across every specialty. A cardiologist, a psychiatrist and an emergency physician evaluating a scribe should ask the same core questions, plus a few about their own visit types.

Most of these tools are not FDA-regulated, so there is no clearance summary to read. The evidence has to come from your own pilot and from published studies.

Last reviewed November 2026 · Independent and vendor-neutral

What does the tool you’re evaluating do?

Jump to the matching checklist. Some answers lead to a different guide.

Physicians and clinicians usually want

  • Accurate notes with no invented findings or medications
  • Little editing time
  • Notes that still sound like them and show their reasoning
  • Time back in the evening

Administrators usually want

  • Sustained adoption, not just licenses bought
  • Measured change in EHR time and burnout
  • A clear consent and recording policy
  • Visibility into coding changes and compliance risk
  • Price per seat compared with the value measured

Ambient scribes

Applies if the tool records the patient visit and drafts the clinical note.

Questions to ask

  • What share of notes are signed without edits, and how is that measured?
  • What is the rate of critical errors (invented findings, wrong medication, wrong side) in the latest independent evaluation?
  • How does it handle accents, non-English visits, interpreters, family members and noisy rooms?
  • Does it support your specialty's visit types and templates (procedures, behavioral health, pediatrics)?
  • Where is audio stored, for how long, and is it used to train models?
  • What happens when a patient declines recording?

Test it locally

  • Pilot for 30 to 60 days with a mix of specialties and clinician types, including heavy and light users.
  • Measure documentation time, total EHR time and after-hours time from EHR audit logs before and during the pilot, not only surveys.
  • Score a blinded sample of notes for quality (PDQI-9 is a common instrument) and count critical errors.
  • Track E/M level distribution before and after, to catch both lost revenue and unintended upcoding.

Red flags

  • Only self-reported time savings
  • Audio kept indefinitely or used for training by default
  • No way to measure how much clinicians edit
  • No consent workflow that respects state recording laws

Chart summarization and search

Applies if the tool reads the existing record and produces a summary, a pre-visit brief or answers to questions about the chart.

Questions to ask

  • Does every statement in the summary link back to the source document so it can be checked?
  • How does it handle conflicting or outdated information (old medication lists, resolved problems)?
  • What does it do when information is missing: say so, or fill the gap?
  • Which parts of the record can it see (outside records, scanned documents, notes from other specialties)?

Test it locally

  • Have clinicians compare summaries against full chart review on a sample of complex patients and count omissions and errors separately. Omissions are harder to notice than errors.

Red flags

  • No source citations
  • Accuracy reported only on simple patients

Patient message replies

Applies if the tool drafts replies to patient portal messages for clinicians or staff to send.

Questions to ask

  • Does a human always review before sending, and does the system prevent unreviewed sending?
  • How does it recognize urgent symptoms in a message and route them?
  • Is the patient told that AI helped draft the reply?
  • Can drafts be set to your reading level and languages?

Test it locally

  • Review a sample of drafts for clinical accuracy, tone and missed red-flag symptoms, and measure whether reply time actually falls.

Red flags

  • Auto-send options for clinical content
  • No urgent-symptom escalation

EHR assistants and clinical question answering

Applies if the tool answers clinical questions, suggests orders or acts as a general assistant inside the EHR.

Questions to ask

  • Does it cite its sources, and are they current guidelines and literature?
  • If it recommends diagnoses or treatments, is it regulated as decision support, and what is its stated intended use?
  • Which large-language-model provider does it use, and does patient data leave your environment?
  • How is it updated, and will you be told when answers may change?

Red flags

  • Unsourced clinical answers
  • No disclosure of the underlying model provider

What published studies show

In the largest multisite study so far (8,581 ambulatory clinicians at five academic health systems), adopting an AI scribe was linked to 16 fewer minutes of documentation per 8 scheduled hours and about half an extra visit per week. After-hours EHR time did not fall significantly. Gains were much larger for clinicians who used the scribe in at least half of visits, but only 32% of adopters did.

JAMA, 2026

Randomized evidence is mixed. In one large randomized comparison of two scribes, both improved burnout and task-load scores, but time in notes fell with only one of the two products.

PMC, 2025
Whatever the tool does, the 12 core questions (evidence, data rights, liability, monitoring, contracts) also apply.

Further reading

Browse nlp & ehr tools

Every listing shows regulatory status, published evidence and named health-system users where public.

Other evaluation guides

Last reviewed November 2026. Educational information, not medical, legal or regulatory advice.

No vendor reviewed, sponsored or edited this guide. Listing is free; no one can pay to change the order.